InVivo Therapeutics Holdings OverviewInVivo Therapeutics Holdings Other Income Expense Net
Other Income/Expense Net for NVIV.
Quarterly Other Income/Expense
$1000.00
↓ 97.78% YoY
As of Sep 30, 2023
Annual Other Income/Expense (TTM)
$399000.00
↑ 495.52% YoY
Trailing 12 months ending Sep 30, 2023